Kadcyla (ado-trastuzumab emtansine)

Kadcyla™ (ado-trastuzumab emtansine or T-DM1) for the treatment of people with HER2-positive metastatic breast cancer (mBC) who have received prior treatment with Herceptin® (trastuzumab)...

Prostate Cancer

Prostate cancer is the most common cancer in men in the UK; affecting 250,000 men. Risk factors for prostate cancer include age (average age at diagnosis is 70), a family history and a Caribbean or...

Antibody Drug Conjugates ADC

The humanized anti-Her2 monoclonal antibody Herceptin (trastuzumab) has become the mainstay in the treatment of Her2-positive breast cancer. Combining trastuzumab with the potent cytotoxic DM1 via a s...

Natural Barriers

Natural killer NK cells

Boosting Body's Natural Tumor-Fighting Protein May Aid Cancer Treatment

New research from the US suggests it may be possible boost a natural tumor-fighting protein that is already present in the body's immune system to enhance the effectiveness of cancer treatment, espec...

Colonoscopy May Reduce Advanced Cancer Risk By 70%

Colonoscopy screening reduces the risk of advanced colorectal cancer by about 70% in average-risk adults. The finding came from a new study led by a researcher at the Perelman School of Medicine at th...

Colonoscopy screening reduces risk of advanced colorectal cancer

(University of Pennsylvania School of Medicine) A new study led by a researcher at the Penn Medicine adds support to current medical recommendations stating that screening colonoscopy substantially re...

Study Finds Advanced Cancer Patients Overoptimistic About Chemotherapy's Ability To Cure

Findings from a nationwide study led by researchers at Dana-Farber Cancer Institute suggest that patients with advanced lung or colorectal cancer are frequently mistaken in their beliefs that chemothe...

Under right conditions, IVF approaches birth rates of natural conception

For the first time, researchers in the USA have calculated cumulative success rates of infertility treatments that use IVF or assisted reproductive technologies (ART), and have showed that overall suc...

New Way to Mass-produce Natural Cancer-killing Cells Offers Hope for Patients

Durham, NC (PRWEB) March 20, 2013 In a new study published by STEM CELLS Translational Medicine, scientists report on a way to produce natural cancer-killing cells in the lab in a quantity that cou...

DPC in charge of preparing Haiti for natural disasters becomes a success story

Not all stories associated with natural disasters in Haiti are filled with tales of gloom and doom. Barely two years following the catastrophic earthquake that leveled portions of Port-au-Prince, the...

Dana-Farber study finds advanced cancer patients overoptimistic about chemotherapy's ability to cure

Findings from a nationwide study led by researchers at Dana-Farber Cancer Institute suggest that patients with advanced lung or colorectal cancer are frequently mistaken in their beliefs that chemothe...

Prostate Imaging Modalities that Can Be Used for Complementary and Alternative Medicine Clinical Studies.

This article provides an overview of imaging modalities that aid in diagnosing, staging, and assessing therapeutic response in prostate cancer. Prostate cancer is the second most common type of cancer...

The link between value motives, value success, and well-being among people diagnosed with cancer.

Objective: This study investigated the relationship between cancer patient's values and cancer related distress.Method: A total of 107 patients with cancer diagnoses completed an anonymous questionnai...

Robotic radical hysterectomy after neoadjuvant chemotherapy in locally advanced cervical cancer.

Abstract Neoadjuvant platinum-based chemotherapy (NACT) plus radical hysterectomy and pelvic lymphadenectomy has been demonstrated to be a valid alternative to chemoradiation in patients with advanced...

Serum insulin-like growth factors and mortality in localised and advanced clinically detected prostate cancer.

CONTEXT: Many studies have reported associations of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) with prostate cancer development, but none have investiga...

A randomized phase 2 study of docetaxel and S-1 versus docetaxel and cisplatin in advanced gastric cancer with an evaluation of SPARC expression for personalized therapy.

The purpose of this study was to compare 2 weekly docetaxel-based regimens as first-line treatments for advanced gastric cancer and to investigate the expression of secreted protein acidic and rich in...